18956075901
當前位置:上海富雨生物科技有限公司>>細胞庫 / 細胞培養>>干細胞>> HLEC(Lens)人晶狀體上
產品名稱:HLEC(Lens)人晶狀體上皮細胞、HLEC(Lens)人晶狀體上皮細胞、HLEC(Lens)人晶狀體上皮細胞、HLEC(Lens)人晶狀體上皮細胞;
Purpose: Trapeziometacarpal osteoarthritis (TMC-OA) is a prevalent hand disorder affecting a growing number of people worldwide. While a multidisciplinary approach might provide additional advantages, the analgesic and anti-inflammatory role of intra-articular oxygen-ozone (O2O3) injections combined with physical therapy is still unknown. To assess the impact of a multimodal therapeutic approach combining O2O3 injections with physical therapy in patients with TMC-OA.
Materials and methods: A prospective open-label study conducted in the Physical and Rehabilitation Medicine Unit of the Renato Dulbecco University Hospital of Catanzaro. We assessed patients with TMC-OA who had not responded to standard medical therapy. Participants received O2O3 therapy and targeted physical therapy for 4?weeks. Pain relief, muscle strength, and physical functioning were assessed at baseline and after 4, 12 and 24?weeks (respectively T0, T1, T2, and T3).
Results: Seventeen patients with a mean age of 67.1?±?6.1?years were included in the study. Short-term improvements in pain intensity were o9plerved (T0: 6.221?±?1.514; T1: 3.172?±?1.1451; p .001) and were maintained over a 24-week follow-up period (T0: 6.221?±?1.514; T3: 4.393?±?1.438; p: 0.006). Significant changes were reported also in terms of muscle strength and physical functioning. O2O3 therapy was well-tolerated with no adverse effects.
Conclusions: A combination of O2O3 injections and physical therapy might be considered in patients with TMC-OA. Further investigation is warranted to assess the effectiveness of O2O3 therapy in managing TMC-OA.
請輸入賬號
請輸入密碼
請輸驗證碼
以上信息由企業自行提供,信息內容的真實性、準確性和合法性由相關企業負責,化工儀器網對此不承擔任何保證責任。
溫馨提示:為規避購買風險,建議您在購買產品前務必確認供應商資質及產品質量。